Status: Recruiting
Psilocybin Therapy for Depression in Parkinson's Disease
The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.
Participants needed: 60
Trial details
Phase: Phase 2Age: 40-80Biological sex: AllType: InterventionalSponsor: Joshua Woolley, MD, PhDUpdated: Aug 7, 2026Locations: 1
Eligibility criteria
Age 40 to 80 [+5]
Psychotic symptoms involving loss of insight [+3]